Skoosh
Skoosh is an early-stage deep-tech startup based in Edinburgh, Scotland, and a member of Cohort 4 of ChipStart UK, the UK government-backed incubator run by Silicon Catalyst.UK.
About
Skoosh is an early-stage deep-tech startup based in Edinburgh, Scotland, and a member of Cohort 4 of ChipStart UK, the UK government-backed incubator run by Silicon Catalyst.UK. It is building the measurement layer for biomanufacturing, developing proprietary sensing technology that provides rapid, quantitative at-line and eventually in-line insight into living cells, enabling automated closed-loop bioprocesses and scalable bio-derived products.
Capital graph
Founders / team· 2
Comparable companies· by market
This company
BusinessLatest roundTotal raisedDate- Skoosh
Rapid quantitative live-cell sensing and measurement for biomanufacturing, enabling automated closed-loop bioprocess control
—
United States
BusinessLatest roundTotal raisedDate- Convoke
AI operating system for biopharma R&D that aggregates data, automates routine research tasks and generates decision and regulatory documents
Seed · $9M · 2025-08
$9M - DeepLook Medica
Automates image measurement and segmentation across medical imaging platforms
Seed · $2M · 2024-02
$2M - Opentrons
Pipetting automation robots and software for life science labs, plus OpentronsAI for generating protocols from natural language.
Series D+ · 2026-10
—
China
BusinessLatest roundTotal raisedDateEurope
BusinessLatest roundTotal raisedDate- Vitestro
Developed a device that integrates AI with ultrasound imaging and robotics to automate blood collection
Series B · $120M · 2026-03
$120M - Silvia Bio
Biologics manufacturing process optimization: bioinformatics analysis + cell assay kits + licensable culture media additives
Seed · $4M · 2026-10
$4M - Arsenale Bioyards
Advanced bioreactors combined with AI-driven software to optimize fermentation in biomanufacturing
Undisclosed · $10M · 2025-03
$10M
Other / unspecified
BusinessLatest roundTotal raisedDate- QT Sense
Quantum sensing platform that tracks real-time signals such as stress and free radicals in living cells
$12M · 2026-03
$12M - OutPost Bio
Automated wet lab + machine learning to generate human microbiome data and predict microbial effects of drugs/products
Pre-Seed · $7M · 2026-03
$7M - ChemT Biotechnology
CelMo AI virtual cell platform helping biopharma/CDMO companies improve cell culture and antibody production efficiency
Seed · $5M · 2026-06
$5M
Confirmed rounds only. Matched on subsector, sector, stage and funding scale — each verifiable on the company profiles.
Investors that may fit
Ranked by each firm’s deals in this sector over the last 24 months, weighted by nearby stage and shared geography. Indicative only — no rating judgment.